Gainers
- SeaStar Medical Holding ICU shares moved upwards by 42.7% to $1.1 during Thursday's pre-market session. The company's market cap stands at $21.3 million.
- Petros Pharma PTPI shares increased by 13.72% to $1.74. The market value of their outstanding shares is at $3.6 million.
- PTC Therapeutics PTCT stock increased by 12.19% to $23.0. The market value of their outstanding shares is at $1.7 billion.
- SAB Biotherapeutics SABS stock moved upwards by 11.2% to $0.69. The market value of their outstanding shares is at $36.1 million.
- Nuwellis NUWE stock increased by 10.24% to $1.07. The market value of their outstanding shares is at $1.9 million.
- 60 Degrees SXTP stock rose 9.46% to $0.83. The company's market cap stands at $4.8 million.
Losers
- CollPlant Biotechnologies CLGN shares decreased by 19.5% to $4.17 during Thursday's pre-market session. The market value of their outstanding shares is at $47.7 million.
- Lipella Pharmaceuticals LIPO stock decreased by 13.99% to $1.23. The company's market cap stands at $7.1 million.
- Yield10 Bioscience YTEN stock decreased by 13.23% to $0.31. The market value of their outstanding shares is at $3.6 million.
- GlucoTrack GCTK shares declined by 12.74% to $0.2. The market value of their outstanding shares is at $4.2 million.
- Nkarta NKTX shares decreased by 9.22% to $2.76. The market value of their outstanding shares is at $135.4 million.
- Sientra SIEN stock decreased by 9.1% to $1.5. The market value of their outstanding shares is at $16.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
GCTKGlucoTrack Inc
$0.26440.15%
ICUSeaStar Medical Holding Corp
$2.052.94%
LIPOLipella Pharmaceuticals Inc
$3.172.25%
NKTXNkarta Inc
$2.35-6.00%
NUWENuwellis Inc
$1.114.72%
PTCTPTC Therapeutics Inc
$45.35-0.46%
PTPIPetros Pharmaceuticals Inc
$0.28801.19%
SABSSAB Biotherapeutics Inc
$4.515.37%
SXTP60 Degrees Pharmaceuticals Inc
$1.268.62%
YTENYield10 Bioscience Inc
$0.510045.7%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in